Allurion Technologies Inc. (ALUR)

PNK – Real Time Price. Currency in USD

2.94

-2.97 (-50.25%)

At close: Jun 26, 2026, 4:00 PM EDT

02.06.2026

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (OTCQB: ALUR), a pioneer in metabolically healthy weight loss, today announced successful early traction in the launch of the Allurion Program in the United States, marked by strong clinical outcomes, rapid account growth, high re-order rates, and performance exceeding internal expectations. First shipments of the Allurion Smart Capsule were completed in April, with the first U.S. patients treated that same month. Early clinical outcom.

12.03.2026

Allurion Advances Plan to Regain Listing Compliance

NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (the “Company”) (OTCID: ALUR), a pioneer in metabolically healthy weight loss, announced today that it has appealed the decision by the New York Stock Exchange (the “NYSE”) to initiate delisting proceedings against Allurion's securities pursuant to Section 802.01B of the NYSE's Listed Company Manual, which requires listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least.

11.03.2026

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (OTCID: ALUR), a pioneer in metabolically healthy weight loss, today announced that it has officially begun training and on‑boarding partner accounts across the United States, including large academic medical centers and private practices. The company has begun manufacturing FDA-approved product and expects to begin shipping in April. This milestone represents a pivotal step in the company's commercial expansion into the world's larges.

06.03.2026

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of Allurion Technologies, Inc. (the “Company”) from the NYSE. NYSE Regulation reached its decision to commence proceedings to delist the Company's Securities pursuant to Section 802.01B of the NYSE's Listed Company Manual because the Company had fallen below the NYSE's.

02.03.2026

Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, has received notice from the New York Stock Exchange (NYSE) that it intends to initiate delisting proceedings against Allurion after the Company was unable to demonstrate that it had regained compliance with Section 802.01B of the Listed Company Manual requiring listed companies to maintain either (i) at least $50 million in stockholders' equity or (ii) at le.

02.03.2026

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of Allurion Technologies, Inc. (the “Company”) from the NYSE. Trading in these Securities will continue on the NYSE until such time as described below. Symbol Description ALUR Common stock, par value $0.0001 per share ALUR WS Warrants to purchase 0.056818 shares of com.

27.02.2026

Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?

Here is how Allurion Technologies, Inc. (ALUR) and McKesson (MCK) have performed compared to their sector so far this year.

Videos

No Data

There is no data to display

Press releases

02.06.2026

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

12.03.2026

Allurion Advances Plan to Regain Listing Compliance

11.03.2026

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

06.03.2026

Allurion Technologies Inc. (ALUR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Allurion Technologies Inc. (ALUR)

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Allurion Advances Plan to Regain Listing Compliance

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?

Videos

No Data

Press releases

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Allurion Advances Plan to Regain Listing Compliance

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Allurion Advances Plan to Regain Listing Compliance

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?

Videos

No Data

Press releases

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Allurion Advances Plan to Regain Listing Compliance

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Search stocks

Allurion Technologies Inc. (ALUR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Allurion Technologies Inc. (ALUR)

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Allurion Advances Plan to Regain Listing Compliance

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?

Videos

No Data

Press releases

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Allurion Advances Plan to Regain Listing Compliance

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Allurion Advances Plan to Regain Listing Compliance

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?

Videos

No Data

Press releases

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Allurion Advances Plan to Regain Listing Compliance

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)